Variant report
Variant | nsv582063 |
---|---|
Chromosome Location | chr2:57175087-57213903 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:3)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:3 , 50 per page) page:
1
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000233251 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs529631899 | chr2:57191008-57191009 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs549865256 | chr2:57191077-57191078 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs569087099 | chr2:57191127-57191128 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs6725604 | chr2:57191136-57191137 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs546834495 | chr2:57191157-57191158 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs566777087 | chr2:57191180-57191181 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs527919903 | chr2:57191231-57191232 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs529252065 | chr2:57191240-57191241 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs572012169 | chr2:57191244-57191245 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs113611675 | chr2:57191279-57191280 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs112874548 | chr2:57191300-57191301 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs114177253 | chr2:57191331-57191332 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs113066306 | chr2:57191351-57191352 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs536217292 | chr2:57191379-57191380 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs556271050 | chr2:57191386-57191387 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs576104453 | chr2:57191422-57191423 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs200790532 | chr2:57191424-57191425 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs370411519 | chr2:57191448-57191449 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs180905624 | chr2:57191449-57191450 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs143329413 | chr2:57191459-57191460 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs185563954 | chr2:57191514-57191515 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs560992571 | chr2:57191519-57191520 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs150969374 | chr2:57191537-57191538 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs543030804 | chr2:57191622-57191623 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs191503704 | chr2:57191623-57191624 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs532236113 | chr2:57191635-57191636 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs552262614 | chr2:57191642-57191643 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs571871959 | chr2:57191719-57191720 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs72809219 | chr2:57191727-57191728 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs17048553 | chr2:57191733-57191734 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
31 | rs539750070 | chr2:57193641-57193642 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs373998865 | chr2:57193642-57193643 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs368109926 | chr2:57193648-57193649 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs17048562 | chr2:57193680-57193681 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
35 | rs541549665 | chr2:57193706-57193707 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs180766072 | chr2:57193731-57193732 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs183707800 | chr2:57193753-57193754 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs1318764 | chr2:57193758-57193759 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
39 | rs189312536 | chr2:57193841-57193842 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs11888362 | chr2:57193872-57193873 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
41 | rs529647596 | chr2:57193887-57193888 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs368377307 | chr2:57193904-57193905 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs552126946 | chr2:57194014-57194015 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs60562169 | chr2:57194015-57194016 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs546201884 | chr2:57194023-57194024 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs397957788 | chr2:57194026-57194027 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs568555144 | chr2:57194027-57194028 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs181286814 | chr2:57194038-57194039 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs375997792 | chr2:57194047-57194048 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs528509327 | chr2:57194053-57194054 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Adrenal tumor | 17535989 | CNVD |
Breast cancer | 21264507 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Medulloblastoma | 17522785 | CNVD |
Cancer | 23418310 | CNVD |
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Prostate cancer | 18632612 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Autism | 17483303 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Medulloblastoma | 20607354 | CNVD |
Leukemia | 18628472 | CNVD |
Autism | 22495311 | CNVD |
Autism | 18522746 | CNVD |
Breast cancer | 21785460 | CNVD |
Lung cancer | 18438408 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 21508638 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Williams Syndrome | 20824207 | CNVD |
Breast cancer | 16272173 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Ovarian cancer | 21720365 | CNVD |
abnormal development | 18461090 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 16397240 | CNVD |
Chronic lymphocytic leukemia | 17053054 | CNVD |
Hereditary non-polyposis colorectal cancer | 19566914 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Developmental delay | 21147756 | CNVD |
Mental retardation | 19951919 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Microcephaly | 20799320 | CNVD |
camptodactyly | 20799320 | CNVD |
cognitive delay | 20799320 | CNVD |
prenatal and postnatal growth deficiency | 20799320 | CNVD |
ptosis of eyelids | 20799320 | CNVD |
Maculopathy | 20981449 | CNVD |
2p16.1 microdeletion syndrome | 22283845 | CNVD |
Autism | 22579565 | CNVD |
Autism | 16963482 | CNVD |
Autism | 21750575 | CNVD |
idiopathic intellectual disability | 16963482 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Follicular lymphoma | 17699855 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:57191000-57191800 | Enhancers | Breast Myoepithelial Primary Cells | Breast |
2 | chr2:57193600-57194400 | Enhancers | HUES48 Cell Line | embryonic stem cell |
3 | chr2:57193600-57194400 | Enhancers | HUES6 Cell Line | embryonic stem cell |
4 | chr2:57193600-57194400 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
5 | chr2:57194200-57194400 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
6 | chr2:57194400-57196200 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
7 | chr2:57194400-57196200 | Weak transcription | HUES6 Cell Line | embryonic stem cell |
8 | chr2:57194400-57196200 | Weak transcription | iPS-15b Cell Line | embryonic stem cell |
9 | chr2:57196200-57196600 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
10 | chr2:57196200-57196600 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
11 | chr2:57196200-57196800 | Enhancers | HUES6 Cell Line | embryonic stem cell |
12 | chr2:57196200-57196800 | Enhancers | HUES64 Cell Line | embryonic stem cell |
13 | chr2:57196200-57197600 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
14 | chr2:57198400-57199800 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
15 | chr2:57208400-57208800 | Enhancers | HSMM | muscle |